The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124776042 12477604 2 F 201604 20160808 20160617 20160809 EXP US-BAYER-2016-076996 BAYER 77.00 YR E F Y 0.00000 20160809 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124776042 12477604 1 PS NEXAVAR SORAFENIB 1 200 MG, UNK (AS DIRECTED BY PHYSICIAN) 21923 200 MG FILM-COATED TABLET
124776042 12477604 2 SS NEXAVAR SORAFENIB 1 Oral 400 MG, BID BXH8GZ2 21923 400 MG FILM-COATED TABLET BID
124776042 12477604 3 SS NEXAVAR SORAFENIB 1 Oral 400 MG, BID BXH9XU1 21923 400 MG FILM-COATED TABLET BID
124776042 12477604 4 C ENOXAPARIN ENOXAPARIN 1 0
124776042 12477604 5 C FLUTICASONE FLUTICASONEFLUTICASONE PROPIONATE 1 0
124776042 12477604 6 C HUMALOG INSULIN LISPRO 1 0
124776042 12477604 7 C HYDROCODONE BITARTRATE AND ACETAMINOPHEN ACETAMINOPHENHYDROCODONE BITARTRATE 1 0
124776042 12477604 8 C LANTUS INSULIN GLARGINE 1 0
124776042 12477604 9 C LEVOTHYROXIN LEVOTHYROXINE 1 135 0
124776042 12477604 10 C LEVOTHYROXIN LEVOTHYROXINE 1 150 0
124776042 12477604 11 C LOSARTAN POTASSIUM. LOSARTAN POTASSIUM 1 UNK 0
124776042 12477604 12 C LOSARTAN POTASSIUM. LOSARTAN POTASSIUM 1 UNK 0
124776042 12477604 13 C NAPROXEN. NAPROXEN 1 0
124776042 12477604 14 C OXYCODONE/APAP ACETAMINOPHENOXYCODONE HYDROCHLORIDE 1 0
124776042 12477604 15 C PANTOPRAZOLE PANTOPRAZOLE SODIUM 1 0
124776042 12477604 16 C SIMVASTATIN. SIMVASTATIN 1 0
124776042 12477604 17 C VOLTAREN DICLOFENAC SODIUM 1 0
124776042 12477604 18 C AMLODIPINE AMLODIPINE BESYLATE 1 0
124776042 12477604 19 C HYDROCHLOROTHIAZIDE. HYDROCHLOROTHIAZIDE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124776042 12477604 1 Thyroid cancer
124776042 12477604 2 Thyroid cancer
124776042 12477604 3 Thyroid cancer

Outcome of event

Event ID CASEID OUTC COD
124776042 12477604 DE
124776042 12477604 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
124776042 12477604 Alopecia
124776042 12477604 Blood pressure systolic increased
124776042 12477604 Death
124776042 12477604 Dizziness
124776042 12477604 Feeling cold
124776042 12477604 Glossitis
124776042 12477604 Glossodynia
124776042 12477604 Headache
124776042 12477604 Muscle spasms
124776042 12477604 Myalgia
124776042 12477604 Neuralgia
124776042 12477604 Oral pain
124776042 12477604 Pain
124776042 12477604 Stomatitis
124776042 12477604 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124776042 12477604 1 20160407 201604 0
124776042 12477604 2 20160413 0
124776042 12477604 3 2016 2016 0